Bard Associates’s CME Group CME Stock Holding History

Bard Associates’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87K	Buy	13 +4	+44%	+$1.11K	﹤0.01%	281
2026 Q1	$2.66K	Buy	+9	New	+$2.67K	﹤0.01%	263

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bard Associates's CME Position: Q2 2026 in Review

Bard Associates increased its CME Group (CME) stake by 44% in Q2 2026, buying an estimated $1.11K and bringing the position to 13 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Bard Associates first reported a position in CME in Q1 2026 and has held it in 2 quarters since. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Bard Associates held 13 shares of CME Group worth $2.87K as of Q2 2026.
Bard Associates bought 4 CME Group shares in Q2 2026, an estimated $1.11K.
CME Group made up ﹤0.01% of Bard Associates's portfolio in Q2 2026, its #281 holding.
Bard Associates first reported a position in CME Group in Q1 2026 and has held it in 2 quarters since.
1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.